Search Results - "Deroose, Christophe"

The LUTIA trial: a small step for PRRT, a giant leap for intra-arterial radionuclide therapy trial methodology by Deroose, Christophe M.

Get full text

Molecular Imaging of Gastroenteropancreatic Neuroendocrine Tumors: Current Status and Future Directions by Deroose, Christophe M, Hindié, Elif, Kebebew, Electron, Goichot, Bernard, Pacak, Karel, Taïeb, David, Imperiale, Alessio

“…Through diagnostic imaging and peptide receptor radionuclide therapy, nuclear medicine has earned a major role in gastroenteropancreatic neuroendocrine tumors…”
Get full text

The role of diffusion-weighted MRI and (18)F-FDG PET/CT in the prediction of pathologic complete response after radiochemotherapy for rectal cancer: a systematic review by Joye, Ines, Deroose, Christophe M, Vandecaveye, Vincent, Haustermans, Karin

“…After neoadjuvant radiochemotherapy (RCT) for locally advanced rectal cancer, 15-27% of the patients experience a pathological complete response (pCR). This…”
Get full text

Use of modern imaging methods to facilitate trials of metastasis-directed therapy for oligometastatic disease in prostate cancer: a consensus recommendation from the EORTC Imaging Group by Lecouvet, Frédéric E, Oprea-Lager, Daniela E, Liu, Yan, Ost, Piet, Bidaut, Luc, Collette, Laurence, Deroose, Christophe M, Goffin, Karolien, Herrmann, Ken, Hoekstra, Otto S, Kramer, Gem, Lievens, Yolande, Lopci, Egesta, Pasquier, David, Petersen, Lars J, Talbot, Jean-Noël, Zacho, Helle, Tombal, Bertrand, deSouza, Nandita M

“…Oligometastatic disease represents a clinical and anatomical manifestation between localised and polymetastatic disease. In prostate cancer, as with other…”
Get full text

Joint Reconstruction of Activity and Attenuation in Time-of-Flight PET: A Quantitative Analysis by Rezaei, Ahmadreza, Deroose, Christophe M, Vahle, Thomas, Boada, Fernando, Nuyts, Johan

“…Methods for joint activity reconstruction and attenuation reconstruction of time-of-flight (TOF) PET data provide an effective solution to attenuation…”
Get full text

Somatostatin receptor PET ligands - the next generation for clinical practice by Pauwels, Elin, Cleeren, Frederik, Bormans, Guy, Deroose, Christophe M

“…Somatostatin receptors (SSTRs) are variably expressed by a variety of malignancies. Using radiolabeled somatostatin analogs (SSAs), the presence of SSTRs on…”
Get full text

18F-Labeled Somatostatin Analogs as PET Tracers for the Somatostatin Receptor: Ready for Clinical Use by Leupe, Hannes, Ahenkorah, Stephen, Dekervel, Jeroen, Unterrainer, Marcus, Van Cutsem, Eric, Verslype, Chris, Cleeren, Frederik, Deroose, Christophe M

“…Molecular imaging of the somatostatin receptor plays a key role in the clinical management of neuroendocrine tumors. PET imaging with somatostatin analogs…”
Get full text

Mapping of Pelvic Lymph Node Metastases in Prostate Cancer by Joniau, Steven, Van den Bergh, Laura, Lerut, Evelyne, Deroose, Christophe M, Haustermans, Karin, Oyen, Raymond, Budiharto, Tom, Ameye, Filip, Bogaerts, Kris, Van Poppel, Hein

“…Abstract Background Opinions about the optimal lymph node dissection (LND) template in prostate cancer differ. Drainage and dissemination patterns are not…”
Get full text

Characterization of a preclinical PET insert in a 7 tesla MRI scanner: beyond NEMA testing by Gsell, Willy, Molinos, Cesar, Correcher, Carlos, Belderbos, Sarah, Wouters, Jens, Junge, Sven, Heidenreich, Michael, Velde, Greetje Vande, Rezaei, Ahmadreza, Nuyts, Johan, Cawthorne, Christopher, Cleeren, Frederik, Nannan, Lise, Deroose, Christophe M, Himmelreich, Uwe, Gonzalez, Antonio J

“…This study evaluates the performance of the Bruker positron emission tomograph (PET) insert combined with a BioSpec 70/30 USR magnetic resonance imaging (MRI)…”
Get more information

International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheres by Levillain, Hugo, Bagni, Oreste, Deroose, Christophe M., Dieudonné, Arnaud, Gnesin, Silvano, Grosser, Oliver S., Kappadath, S. Cheenu, Kennedy, Andrew, Kokabi, Nima, Liu, David M., Madoff, David C., Mahvash, Armeen, Martinez de la Cuesta, Antonio, Ng, David C. E., Paprottka, Philipp M., Pettinato, Cinzia, Rodríguez-Fraile, Macarena, Salem, Riad, Sangro, Bruno, Strigari, Lidia, Sze, Daniel Y., de Wit van der veen, Berlinda J., Flamen, Patrick

“…Purpose A multidisciplinary expert panel convened to formulate state-of-the-art recommendations for optimisation of selective internal radiation therapy (SIRT)…”
Get full text

18F-AlF-NOTA-Octreotide Outperforms 68Ga-DOTATATE/NOC PET in Neuroendocrine Tumor Patients: Results from a Prospective, Multicenter Study by Pauwels, Elin, Cleeren, Frederik, Tshibangu, Térence, Koole, Michel, Serdons, Kim, Boeckxstaens, Lennert, Dekervel, Jeroen, Vandamme, Timon, Lybaert, Willem, Van den Broeck, Bliede, Laenen, Annouschka, Clement, Paul M, Geboes, Karen, Van Cutsem, Eric, Stroobants, Sigrid, Verslype, Chris, Bormans, Guy, Deroose, Christophe M

“…18F-labeled somatostatin analogs (SSAs) could represent a valid alternative to the current gold standard, 68Ga-labeled SSAs, for somatostatin receptor imaging…”
Get full text

[18F]AlF-NOTA-octreotide PET imaging: biodistribution, dosimetry and first comparison with [68Ga]Ga-DOTATATE in neuroendocrine tumour patients by Pauwels, Elin, Cleeren, Frederik, Tshibangu, Térence, Koole, Michel, Serdons, Kim, Dekervel, Jeroen, Van Cutsem, Eric, Verslype, Chris, Van Laere, Koen, Bormans, Guy, Deroose, Christophe M.

“…Purpose The widespread use of gallium-68-labelled somatostatin analogue (SSA) PET, the current standard for somatostatin receptor (SSTR) imaging, is limited by…”
Get full text

Resin-Based Yttrium-90 Radioembolization as a Bridging or Downstaging Treatment to Liver Transplantation for Hepatocellular Carcinoma by Bonne, Lawrence, Deroose, Christophe M., Verslype, Chris, Monbaliu, Diethard, Dekervel, Jeroen, Van Laeken, Charlotte, Vandecaveye, Vincent, Laenen, Annouschka, Pirenne, Jacques, Maleux, Geert

“…To evaluate the outcomes of resin-based yttrium-90 (90Y) transarterial radioembolization (TARE) for hepatocellular carcinoma (HCC) as a bridging or downstaging…”
Get full text

Personalised radioembolization improves outcomes in refractory intra-hepatic cholangiocarcinoma: a multicenter study by Levillain, Hugo, Duran Derijckere, Ivan, Ameye, Lieveke, Guiot, Thomas, Braat, Arthur, Meyer, Carsten, Vanderlinden, Bruno, Reynaert, Nick, Hendlisz, Alain, Lam, Marnix, Deroose, Christophe M., Ahmadzadehfar, Hojjat, Flamen, Patrick

“…Purpose Reported outcomes of patients with intra-hepatic cholangiocarcinoma (IH-CCA) treated with radioembolization are highly variable, which indicates…”
Get full text

Bismuth-213 for Targeted Radionuclide Therapy: From Atom to Bedside by Ahenkorah, Stephen, Cassells, Irwin, Deroose, Christophe M, Cardinaels, Thomas, Burgoyne, Andrew R, Bormans, Guy, Ooms, Maarten, Cleeren, Frederik

“…In contrast to external high energy photon or proton therapy, targeted radionuclide therapy (TRNT) is a systemic cancer treatment allowing targeted irradiation…”
Get full text

Could Autoimmune Disease Contribute to the Abscopal Effect in Metastatic Hepatocellular Carcinoma? by Beyls, Carolien, Haustermans, Karin, Deroose, Christophe M., Pans, Steven, Vanbeckevoort, Dirk, Verslype, Chris, Dekervel, Jeroen

Get full text

18 F-Labeled Somatostatin Analogs as PET Tracers for the Somatostatin Receptor: Ready for Clinical Use by Leupe, Hannes, Ahenkorah, Stephen, Dekervel, Jeroen, Unterrainer, Marcus, Van Cutsem, Eric, Verslype, Chris, Cleeren, Frederik, Deroose, Christophe M

“…Molecular imaging of the somatostatin receptor plays a key role in the clinical management of neuroendocrine tumors. PET imaging with somatostatin analogs…”
Get full text

Inflammation-Based Index and 68Ga-DOTATOC PET–Derived Uptake and Volumetric Parameters Predict Outcome in Neuroendocrine Tumor Patients Treated with 90Y-DOTATOC by Pauwels, Elin, Van Binnebeek, Sofie, Vandecaveye, Vincent, Baete, Kristof, Vanbilloen, Hubert, Koole, Michel, Mottaghy, Felix M, Haustermans, Karin, Clement, Paul M, Nackaerts, Kristiaan, Van Cutsem, Eric, Verslype, Chris, Deroose, Christophe M

“…We performed post hoc analyses on the utility of pretherapeutic and early interim 68Ga-DOTATOC PET tumor uptake and volumetric parameters and a recently…”
Get full text

18F-FDG PET/CT Sheds Light on a Case of Hyponatremia by Gans, Delphine, Braet, Pauline, Bidakhvidi, Niloefar Ahmadi, Deroose, Christophe M, Decallonne, Brigitte, Jentjens, Sander

“…A 76-y-old man with hypoosmolar hyponatremia of unknown origin was referred to the nuclear medicine department for 18F-FDG PET/CT to exclude a malignant cause…”
Get full text

18 F-FDG PET/CT Sheds Light on a Case of Hyponatremia by Gans, Delphine, Braet, Pauline, Bidakhvidi, Niloefar Ahmadi, Deroose, Christophe M, Decallonne, Brigitte, Jentjens, Sander

“…A 76-y-old man with hypoosmolar hyponatremia of unknown origin was referred to the nuclear medicine department for F-FDG PET/CT to exclude a malignant cause…”
Get full text